MaggieSantos
☆    

Portugal,
2017-04-26 20:20
(3349 d 02:53 ago)

Posting: # 17271
Views: 4,234
 

 Narrow Therapeutic Index- valproic acid and derivatives [Regulatives / Guidelines]

Post reply
Dear colleagues,

Concerning valproic acid and derivatives is not consentaneous that it should be considered as a narrow therapeutic índex for bioequivalence purposes. I know that for FDA it is a NTI. Do you have information for EMA, for individual European countries and for other countries around the World.

Depending on the submission country, the BE interval will differ.
Please, feel free to comment.

I need the more information I can get.

Kind Regards

MaggieSantos
 
DavidManteigas
★    

Portugal,
2017-05-02 14:07
(3343 d 09:06 ago)

@ MaggieSantos
Posting: # 17290
Views: 3,351
 

 Narrow Therapeutic Index- valproic acid and derivatives

Post reply
Hi MaggieSantos,

In the absence of a product specific guideline and a list of NTI drugs in Europe, I would opt for requesting scientific advise if your position is that valproic acid is not a nti drug.

Regards,
David
 
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
345 visitors (0 registered, 345 guests [including 19 identified bots]).
Forum time: 23:14 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5